Related Experiment Video
Updated: Oct 10, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Rab31-dependent regulation of transforming growth factor ß expression in breast cancer cells
Susanne Soelch1, Nathalie Beaufort2, Daniela Loessner3,4
1Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität München, Ismaninger Str. 22, 81576, Munich, Germany.
Background:
The small GTP-binding protein Rab31 plays an important role in the modulation of tumor biological-relevant processes, including cell proliferation, adhesion, and invasion. As an underlying mechanism, Rab31 is presumed to act as a molecular switch between a more proliferative and an invasive phenotype. This prompted us to analyze whether Rab31 overexpression in breast cancer cells affects expression of genes involved in epithelial-to-mesenchymal transition (EMT)-like processes when compared to Rab31 low-expressing cells.
Methods:
Commercially available profiler PCR arrays were applied to search for differentially expressed genes in Rab31 high- and low-expressing CAMA-1 breast cancer cells. Differential expression of selected candidate genes in response to Rab31 overexpression in CAMA-1 cells was validated by independent qPCR and protein assays.
Results:
Gene expression profiling of key genes involved in EMT, or its reciprocal process MET, identified 9 genes being significantly up- or down-regulated in Rab31 overexpressing CAMA-1 cells, with the strongest effects seen for TGFB1, encoding TGF-ß1 (> 25-fold down-regulation in Rab31 overexpressing cells). Subsequent validation analyses by qPCR revealed a strong down-regulation of TGFB1 mRNA levels in response to increased Rab31 expression not only in CAMA-1 cells, but also in another breast cancer cell line, MDA-MB-231. Using ELISA and Western blot analysis, a considerable reduction of both intracellular and secreted TGF-ß1 antigen levels was determined in Rab31 overexpressing cells compared to vector control cells. Furthermore, reduced TGF-ß activity was observed upon Rab31 overexpression in CAMA-1 cells using a sensitive TGF-ß bioassay. Finally, the relationship between Rab31 expression and the TGF-ß axis was analyzed by another profiler PCR array focusing on genes involved in TGF-ß signaling. We found 12 out of 84 mRNAs significantly reduced and 7 mRNAs significantly increased upon Rab31 overexpression.
Conclusions:
Our results demonstrate that Rab31 is a potent modulator of the expression of TGF-ß and other components of the TGF-ß signaling pathway in breast cancer cells.
Insights
Rab31 overexpression in breast cancer cells significantly down-regulates TGF-ß1 expression and impacts TGF-ß signaling. This suggests Rab31 influences tumor invasion by modulating the TGF-ß pathway.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Rab31, a small GTP-binding protein, is implicated in tumor progression, including cell proliferation, adhesion, and invasion.
- Rab31 is hypothesized to function as a molecular switch regulating the transition between proliferative and invasive cellular phenotypes.
Purpose of the Study:
- To investigate the effect of Rab31 overexpression on gene expression related to epithelial-to-mesenchymal transition (EMT) in breast cancer cells.
- To determine if Rab31 influences the expression of genes within the transforming growth factor beta (TGF-ß) signaling pathway.
Main Methods:
- Differential gene expression analysis using PCR arrays in Rab31 high- and low-expressing breast cancer cell lines (CAMA-1, MDA-MB-231).
- Validation of gene and protein expression using quantitative PCR (qPCR), ELISA, and Western blot.
- Assessment of TGF-ß activity using a TGF-ß bioassay.
Main Results:
- Rab31 overexpression led to significant down-regulation of TGFB1 (encoding TGF-ß1) by over 25-fold in CAMA-1 cells, also observed in MDA-MB-231 cells.
- Reduced intracellular and secreted TGF-ß1 protein levels and decreased TGF-ß activity were detected in cells overexpressing Rab31.
- Analysis of TGF-ß signaling pathway genes revealed significant down-regulation of 12 mRNAs and up-regulation of 7 mRNAs upon Rab31 overexpression.
Conclusions:
- Rab31 acts as a significant modulator of TGF-ß1 expression in breast cancer.
- Rab31 influences the TGF-ß signaling pathway, suggesting a role in regulating tumor cell invasion and metastasis.
Related Concept Videos
TGF - β Signaling Pathway
Regulation of Angiogenesis and Blood Supply
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Mitogens and the Cell Cycle
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...

